Severe dermatitis caused by diltiazem

Published in Allergol Immunopathol (Madr). 2012;40:65-7. - vol.40 núm 01

Introduction

To the Editor, Skin rash which caused by drugs shows a high polymorphism, which is determined, on the one hand, by the large amount of drugs used, and on the other hand, by the presence of polymedication, particularly in seriously-ill elderly patients, that increases the possibility for interaction among them, with the attendant risk of morphological expression of medicinal rash. The spectrum of these reactions ranges from mild rash to the most severe forms, which are Stevens-Johnson's syndrome and epidermal toxic necrolysis. The term epidermal necrolysis is a neologism proposed by Lyell1 to indicate necrosis and separation of epidermis. Blisters are merely exudates accumulating under the necrotic epidermis. The necrolysis phenomenon results from massive apoptosis of the epidermal cells, together with the degradation of the adhesion molecules between the basal cells and the basal membrane of the epidermis.2 Stevens-Johnson's syndrome and epidermal toxic necrolysis are considered to be variants of the same disease, based on their similar condition (epidermal necrolysis), similar risk factors, causes and frequent progression from Stevens-Johnson's syndrome to toxic epidermal necrolysis. The main difference between these two conditions resides in the extension of the skin lesions: classified as Stevens-Johnson's syndrome when necrolysis affects less than 10% of the body surface; as superposition of both when it affects from 10 to 30%; and as toxic epidermal necrolysis when it affects over 30% of the body surface.3 We here present the case of a 66-year-old woman, with a history of depressive syndrome treated with mirtazapine and previous cholecystectomy, who in the past...

Bibliography

1. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Haematol. 1956; 68:355-61.
2. Allanore L, Roujeau JC. Clinical and pathogenesis of severe bullous skin reactions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis. En: Pichler W.J., editors. Drug hypersensitivity. Basel: Karger AG; 2007. 267-77.
3. Requena L, Requena C. Síndrome de Stevens-Johnson y Necrólisis epidérmica tóxica. En: Fernández Herrera J., Requena Caballero L., editors. Erupciones cutáneas medicamentosas. Barcelona: Signament Edicions SL; 2003. 153-61.
4. Stern R, Khalsa JH. Cutaneous adverse reactions associated with calcium channel blockers. Ann Intern Med. 1989; 149:829-32.
5. Aihara Y, Ito R, Ito S, Aihara M, Yokota S. Toxic epidermal necrolysis in a child successfully treated with cyclosporine A and methylprednisolone. Pediatr Int. 2007; 49:659-62.
Pubmed
6. Arévalo JM, Lorente JA, González-Herrada C, Jiménez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporine A. J Trauma. 2000; 48:473-8.
Pubmed
7. Khalili B, Bahna SL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol. 2006; 97:272-81.
Pubmed
8. Hashim N, Bandara D, Tan E, Ilchyshyn A. Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate. Acta Derm Veneorol. 2004; 84:90-1.


Miralles, J.C.a; Carbonell, A.a; Sánchez-Guerrero, I.b; Pastor, F.c; Escudero, A.a; Brufau, C.d; López-Andreu, F.e

aAllergology Section, Hospital General Universitario Reina Sofía, Murcia, Spain

bAllergology Section, Hospital General Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain

cPathology Department, Hospital General Universitario Reina Sofía, Murcia, Spain

dDermatology Department, Hospital General Universitario Reina Sofía, Murcia, Spain

eInternal Medicine Department, Hospital General Universitario Reina Sofía, Murcia, Spain